S H Kelkar and Company Limited (NSE:SHK) filed the transcript of its Q1 FY27 earnings conference call on 4 August 2026, pursuant to Regulation 30 of SEBI LODR. The call, held virtually on 29 July 2026, disclosed consolidated revenue from operations of Rs. 662 crore for the quarter ended June 2026, reflecting 14% year-on-year growth.
Key Highlights
- Consolidated revenue from operations grew 14% year-on-year to Rs. 662 crore in Q1 FY27, with both the Fragrance and Flavour segments contributing to growth.
- Consolidated EBITDA rose 21% year-on-year to Rs. 89 crore, with the EBITDA margin improving to 13.4% from 12.6% in Q1 FY26.
- Net debt increased by Rs. 65 crore during the quarter to Rs. 852 crore as of June 2026, attributed to strategic inventory buildup and capacity expansion spending.
- The company recognised exceptional income of approximately Rs. 30 crore in Q1 FY27 relating to an insurance claim for a prior fire incident, with full settlement expected within FY27.
About the Company
S H Kelkar and Company Limited (NSE:SHK), headquartered in Mumbai, is one of India's largest fragrance and flavour manufacturers. The company operates under the Keva brand and serves personal care, home care, and food categories across domestic and international markets, including Europe and the United States. It maintains Research and Development centres and Creative Development Centres as part of its global manufacturing and innovation infrastructure.
Announcement in Detail
During the call, Group CFO Jagdish Agarwal stated that gross margins remained stable year-on-year, supported by a favourable product mix and proactive raw material planning. The Flavour segment recorded broad-based growth across geographies, though management noted that a portion of growth reflected the timing of certain customer orders. Whole-Time Director and Group CEO Kedar Vaze indicated that Flavours revenue of Rs. 112 crore in Q1 FY27 included an estimated Rs. 15 crore of order preponement, with a normalised quarterly run rate of approximately Rs. 95 crore to Rs. 96 crore.
Management also noted that India Fragrance revenues were flat year-on-year, partly due to a high base in Q1 FY26 and a deliberate decision to exit certain low-margin business lines. The Global Ingredients segment saw softer performance on lower demand in select export markets. On foreign exchange, Vaze stated that like-for-like growth was 9%, with an additional 5% contribution from rupee depreciation. Management guided for double-digit revenue growth and improved margins for the full year FY27, while cautioning that quarterly growth may vary depending on order timing and geopolitical conditions.
Impact on Investors
Investors will note that net debt rose to Rs. 852 crore as of June 2026, an increase of Rs. 65 crore during the quarter. The filing shows management attributed this to deliberate inventory accumulation for supply security and ongoing capital expenditure on capacity expansion, while reaffirming a commitment to medium- to long-term deleveraging. Shareholders will observe that higher operating expenses within the Fragrance segment, linked to R&D and Creative Development Centre investments, are expected to weigh on segment margins until corresponding revenue scales up, as disclosed by management during the call.
The disclosed terms indicate that the exceptional income of approximately Rs. 30 crore from the insurance claim has been recognised in Q1 FY27 results. Investors will note that the claim process is described as progressing, with full settlement expected within the current financial year, though the exact timing and final amount remain subject to the claim settlement process.
Sector / Market Context
India's fragrance and flavour industry serves as a key upstream supplier to the fast-moving consumer goods, personal care, and processed food sectors. According to industry estimates cited by FICCI and sector bodies, domestic demand for aroma chemicals and flavour ingredients has expanded alongside rising consumer spending on personal care and packaged food products. Geopolitical developments in West Asia, as referenced during the call, have contributed to freight cost volatility and supply chain uncertainty across the specialty chemicals and ingredients space in recent quarters, affecting procurement planning for manufacturers with significant import dependence.